These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1506127)

  • 41. To P or not to P, is that the question? Rethinking experimental design and data analysis to improve biological significance beyond the statistical significance.
    Neppelenbroek KH; Honório HM; Garlet GP
    J Appl Oral Sci; 2019 Oct; 27():e2019ed001. PubMed ID: 31596371
    [No Abstract]   [Full Text] [Related]  

  • 42. [Application of the Number Needed to Treat to evaluate therapeutic efficacy in each patient].
    Obu S
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2330-2. PubMed ID: 18044176
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical importance cannot be ruled out using mean difference alone.
    Cates C; Karner C
    BMJ; 2015 Nov; 351():h5496. PubMed ID: 26588935
    [No Abstract]   [Full Text] [Related]  

  • 44. Design and publication of work on stability constants.
    Rossotti HS
    Talanta; 1974 Aug; 21(8):809-29. PubMed ID: 18961538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presentation before Publication.
    Lebo D
    Science; 1959 Apr; 129(3354):992. PubMed ID: 17817098
    [No Abstract]   [Full Text] [Related]  

  • 46. An online tool for the calculation and graphical presentation of the NNTnet.
    Coenen S; Colliers A
    J Clin Epidemiol; 2021 May; 133():168-169. PubMed ID: 33484840
    [No Abstract]   [Full Text] [Related]  

  • 47. Bioavailability of Epigallocatechin Gallate Administered With Different Nutritional Strategies in Healthy Volunteers.
    Andreu-Fernández V; Almeida Toledano L; Pizarro N; Navarro-Tapia E; Gómez-Roig MD; de la Torre R; García-Algar Ó
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32438698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Authors' Reply to Nicolas: "Levothyrox
    Concordet D; Gandia P; Montastruc JL; Bousquet-Mélou A; Lees P; Ferran AA; Toutain PL
    Clin Pharmacokinet; 2019 Jul; 58(7):961-963. PubMed ID: 31161456
    [No Abstract]   [Full Text] [Related]  

  • 49. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans.
    Naumovski N; Blades BL; Roach PD
    Antioxidants (Basel); 2015 May; 4(2):373-93. PubMed ID: 26783711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioequivalence study of donepezil hydrochloride tablets in healthy male volunteers.
    Rojanasthien N; Aunmuang S; Hanprasertpong N; Roongapinun S; Teekachunhatean S
    ISRN Pharmacol; 2012; 2012():527679. PubMed ID: 23209934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age and gender dependent bioavailability of R- and R,S-α-lipoic acid: a pilot study.
    Keith DJ; Butler JA; Bemer B; Dixon B; Johnson S; Garrard M; Sudakin DL; Christensen JM; Pereira C; Hagen TM
    Pharmacol Res; 2012 Sep; 66(3):199-206. PubMed ID: 22609537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A; Nave R; Steinijans VW; Baumgärtner E; Bethke TD
    Clin Pharmacokinet; 2006; 45(7):729-36. PubMed ID: 16802853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of Cmax and Tmax in populations after single and multiple drug administrations.
    Tothfalusi L; Endrenyi L
    J Pharmacokinet Pharmacodyn; 2003 Oct; 30(5):363-85. PubMed ID: 14977165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The existence of sequence effect in cross-over bioequivalence trials.
    Zintzaras E
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):241-4. PubMed ID: 11420897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative pharmacokinetics of two nifedipine products in capsule form following single oral administration in healthy volunteers.
    Rawashdeh NM; Battah AH; Irshaid YM; al-Qato MK
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):259-64. PubMed ID: 9358208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of carbamazepine. Part I: A new bioequivalency parameter based on a relative bioavailability trial.
    Kayali A; Tuğlular I; Ertaş M
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):319-25. PubMed ID: 7737233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin.
    Duursema L; Müller FO; Schall R; Middle MV; Hundt HK; Groenewoud G; Steinijans VW; Bliesath H
    Br J Clin Pharmacol; 1995 Jun; 39(6):700-3. PubMed ID: 7654493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presentation of results from bioequivalence studies.
    Sauter R; Steinijans VW; Diletti E; Böhm A; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992 Jul; 30(7):233-56. PubMed ID: 1506127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presentation of results from bioequivalence studies.
    Sauter R; Steinijans VW; Diletti E; Böhm A; Schulz HU
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S7-30. PubMed ID: 1601535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.